|
Numero Folio |
Titulo de Folio |
|
Folio 1 |
An Unknown Risk
Factor for Sepsis in MBPN: ABO Blood Groups |
|
Folio 2 |
Antibiotic
regimens for early-onset neonatal sepsis |
|
Folio 3 |
Antibiotic
regimens for late-onset neonatal sepsis (Review) |
|
Folio 4 |
Biomarkers for
the Diagnosis of Neonatal Sepsis |
|
Folio 5 |
C-Reactive
Protein for Diagnosis of Late-Onset Infections in Newborn |
|
Folio 6 |
Ending the
Culture of Culture-Negative Sepsis in the Neonatal ICU |
|
Folio 7 |
Knowledge gaps
in late-onset neonatal sepsis in preterm |
|
Folio 8 |
Metabolic
responses in neonatal sepsis |
|
Folio 9 |
What's new in
the management of neonatal early-onset sepsis? |
|
Folio 10 |
Neonatal septic
shock, a focus on first line interventions |
|
Folio 11 |
Knowledge gaps
in late-onset neonatal sepsis in preterm |
|
Folio 12 |
Procalcitonin-guided decision for duration of antibiotic in neonates |
|
Folio 13 |
Late-Onset
Sepsis Among Very Preterm Infants |
|
Folio 14 |
The Term
Newborn: Early-Onset Sepsis |
|
Folio 15 |
Vital signs as
physiomarkers of neonatal sepsis |
|
Folio 16 |
Neonatal Sepsis:
A Review of Pathophysiology and Current Management |
|
Folio 17 |
Neonatal Early-Onset Sepsis |
|
Folio 18 |
Early-Onset
Sepsis in Newborns Ped
in Review 2023 |
|
Folio 19 |
Updates in Late-Onset Sepsis: Risk
Assessment, Therapy, and Outcomes |
|
Folio 20 |
What is new in the management of neonatal early-onset sepsis? |
|
Folio 21 |
Reduction of
Duration of Antibiotic Therapy for Suspected Early-Onset Sepsis |
|
Folio 22 |
Diagnóstico de Sepsis neonatal : Presente y futuro |
|
Folio 23 |
Short-Course vs
Long-Course Antibiotic Therapy |
|
Folio 24 |
Fever,
Neutrophil Count, Procalcitonin, and AAP Febrile Infant Guidelines |